S
Shilpa
About Shilpa
Data last updated:
Shilpa is a Director at Surgeway Biosciences Private Limited (since 2023) and Director at Dorphyll Healthcare Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.26 Cr; the largest is Surgeway Biosciences Private Limited at ₹2.76 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Surgeway Biosciences Private Limited U46497KA2023PTC174184 | Director | 27 May 2023 | 2023 | ₹2.76 Cr (FY 2025) | Active |
 Dorphyll Healthcare Private Limited U24299KA2021PTC149000 | Director | 01 Jul 2021 | 2021 | ₹2.50 Cr (FY 2025) | Active |
Board colleagues of Shilpa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hitesh Kumar Madhavkumar | 02458445 | Surgeway Biosciences Private Limited , Dorphyll Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shilpa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shilpa
Shilpa currently holds 2 directorships: Surgeway Biosciences Private Limited (Director, since 27 May 2023, revenue ₹2.76 Cr (FY 2025)); Dorphyll Healthcare Private Limited (Director, since 01 Jul 2021, revenue ₹2.50 Cr (FY 2025)).
Shilpa was first appointed on 01 Jul 2021 as Director at Dorphyll Healthcare Private Limited. The most recent appointment on record is 27 May 2023 at Surgeway Biosciences Private Limited.
The 2 current companies of Shilpa that report revenue have a combined latest revenue of ₹5.26 Cr: Surgeway Biosciences Private Limited ₹2.76 Cr (FY 2025); Dorphyll Healthcare Private Limited ₹2.50 Cr (FY 2025).
The current boards of Shilpa's companies include Hitesh Kumar Madhavkumar (Surgeway Biosciences Private Limited).